Beam Therapeutics: Q3 Earnings Insights

Beam Therapeutics BEAM reported its Q3 earnings results on Wednesday, November 8, 2023 at 06:30 AM.

Here's what investors need to know about the announcement.

Earnings

Beam Therapeutics beat estimated earnings by 8.96%, reporting an EPS of $-1.22 versus an estimate of $-1.34.

Revenue was up $1.39 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.34 which was followed by a 0.53% drop in the share price the next day.

Here's a look at Beam Therapeutics's past performance:

Quarter Q2 2023 Q1 2023 Q4 2022 Q3 2022
EPS Estimate -1.42 -1.34 -1.33 -1.31
EPS Actual -1.08 -1.33 -0.54 -1.56
Revenue Estimate 18.05M 14.08M 12.53M 7.94M
Revenue Actual 20.12M 24.21M 20.04M 15.80M

To track all earnings releases for Beam Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

BEAM Logo
BEAMBeam Therapeutics Inc
$16.91-1.94%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
17.59
Growth
Not Available
Quality
Not Available
Value
22.34
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Comments
Loading...